Webinar series: Cancer Research Week @ QIAGEN!

QIAcancerWeek_700x233_v2_01

Cancer research has come a long way, and is accelerating even faster in the age of next-generation sequencing (NGS). Identifying mutations, discovering biomarkers, and profiling DNA and RNA from single cells has given us more specific and personalized insights than ever, and advances in NGS are largely to thank for these opportunities.

This September, we’re offering a 4-part webinar series to explore the latest in NGS technology for cancer research, from Unique Molecular Indices (UMIs) that enable accurate quantification of reads to targeted DNA sequencing, improved miRNA-seq for liquid biopsy, and single cell NGS solutions. Join us and discover new technology to help you in your mission to defeat cancer!

Check out the abstracts below – sign up just once and you’ll be registered for all 4! Scheduling conflict? No problem. When you sign up, you’ll be put on the list to receive the recording afterward.

Sign up today!

 

Part I: Introduction to Unique Molecular Index (UMI) technology for targeted sequencing
Speaker: Christine Davis
Friday, September 8, 4 p.m. EDT

This webinar introduces a novel digital sequencing technology that incorporates Unique Molecular Indices (UMIs) into the DNA or RNA sequences before PCR amplification takes place, to eliminate errors such as PCR duplication and amplification bias as well as sequencing bias. Join us to learn how UMI technology works and how it is used in QIAGEN’s QIAseq sequencing solutions. Find out how to improve your NGS data with the accuracy of UMIs!

Part II: Targeted DNA-seq for cancer mutation detection
Speaker: Zhong Wu, PhD
Monday, September 11, 4 p.m. EDT

This webinar introduces the QIAseq Targeted DNA Panels, which use Unique Molecular Indices (UMIs) and Single Primer Extension (SPE) technology to improve downstream analysis of difficult-to-sequence genes on Illumina and Thermo Fisher NGS instruments. QIAGEN uses its proprietary knowledge base to design panels for different cancer types, carrier testing, cardiomyopathy and other areas of interest. In addition, QIAGEN offers full coverage of the human genome, allowing researchers to build custom panels for their specific applications.

Part III: miRNA-seq from liquid biopsy: robust detection from the lowest sample amounts
Speaker: Jonathan M. Shaffer, PhD
Tuesday, September 12, 4 p.m. EDT

miRNA-seq has historically been hindered by a tedious, gel-dependent workflow and low data quality due to adapter dimers and contaminating RNA species. This webinar introduces QIAseq miRNA Library Kit that is specifically designed to overcome these challenges. The innovative, gel-free workflow enables the preparation of robust libraries from even the most difficult, low RNA content biofluids. QIAseq miRNA maximizes on-target miRNA reads, dynamic range and, most importantly, your discovery potential.

Part IV: Next-generation sequencing in single-cell applications
Speaker: Samuel J. Rulli, PhD
Thursday, September 14, 4 p.m. EDT

QIAGEN has developed complete cell-to-library solutions for DNA and RNA sequencing libraries from single cells, as well as the novel QIAscout system for reliable single-cell isolation. Join us to learn more!

 

 

Ali Bierly

Ali Bierly, PhD is a Global Market Manager in Translational Sciences at QIAGEN, and has written on a number of scientific topics in the biotech industry as the author of QIAGEN's Reviews Online. She received her PhD from Cornell University in 2009, studying the immune response to a protozoan parasite, Toxoplasma gondii. Ali has a keen interest in the emerging importance of microRNA and other circulating nucleic acids as biomarkers for disease.

Your email address will not be published. Required fields are marked *